Fernwood Investment Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-83,780
| Closed | -$2.48M | – | 720 |
|
|
2023
Q4 | $2.48M | Sell |
83,780
-2,500
| -3% | -$49.8K | 0.82% | 32 |
|
|
2023
Q3 | $1.37M | Sell |
86,280
-42,400
| -33% | -$705K | 0.49% | 58 |
|
|
2023
Q2 | $2.43M | Sell |
128,680
-17,500
| -12% | -$207K | 0.86% | 31 |
|
|
2023
Q1 | $561K | Hold |
146,180
| – | – | 0.22% | 106 |
|
|
2022
Q4 | $725K | Sell |
146,180
-2,660
| -2% | -$14.4K | 0.3% | 91 |
|
|
2022
Q3 | $711K | Sell |
148,840
-10,000
| -6% | -$52.7K | 0.3% | 89 |
|
|
2022
Q2 | $715K | Hold |
158,840
| – | – | 0.31% | 88 |
|
|
2022
Q1 | $756K | Buy |
158,840
+4,000
| +3% | +$22.1K | 0.27% | 100 |
|
|
2021
Q4 | $1.15M | Buy |
154,840
+3,500
| +2% | +$21.8K | 0.38% | 77 |
|
|
2021
Q3 | $858K | Hold |
151,340
| – | – | 0.29% | 96 |
|
|
2021
Q2 | $997K | Hold |
151,340
| – | – | 0.33% | 87 |
|
|
2021
Q1 | $1.23M | Buy |
151,340
+2,000
| +1% | +$16.3K | 0.45% | 64 |
|
|
2020
Q4 | $963K | Sell |
149,340
-5,000
| -3% | -$29.2K | 0.38% | 78 |
|
|
2020
Q3 | $556K | Sell |
154,340
-25,000
| -14% | -$101K | 0.26% | 96 |
|
|
2020
Q2 | $825K | Hold |
179,340
| – | – | 0.41% | 72 |
|
|
2020
Q1 | $612K | Sell |
179,340
-4,660
| -3% | -$20.4K | 0.39% | 72 |
|
|
2019
Q4 | $939K | Hold |
184,000
| – | – | 0.45% | 59 |
|
|
2019
Q3 | $445K | Buy |
184,000
+12,000
| +7% | +$31.9K | 0.22% | 116 |
|
|
2019
Q2 | $373K | Sell |
172,000
-15,000
| -8% | -$35.5K | 0.2% | 102 |
|
|
2019
Q1 | $507K | Hold |
187,000
| – | – | 0.27% | 85 |
|
|
2018
Q4 | $898K | Buy |
187,000
+1,000
| +0.5% | +$6.07K | 0.58% | 53 |
|
|
2018
Q3 | $1.76M | Sell |
186,000
-3,500
| -2% | -$33.6K | 0.93% | 33 |
|
|
2018
Q2 | $1.84M | Sell |
189,500
-4,000
| -2% | -$42.2K | 1% | 27 |
|
|
2018
Q1 | $2.04M | Sell |
193,500
-31,000
| -14% | -$306K | 1.14% | 22 |
|
|
2017
Q4 | $1.44M | Buy |
224,500
+4,000
| +2% | +$24.7K | 0.77% | 42 |
|
|
2017
Q3 | $1.69M | Buy |
220,500
+2,000
| +0.9% | +$13.3K | 1.06% | 25 |
|
|
2017
Q2 | $1.55M | Buy |
+218,500
| New | +$1,000K | 1.13% | 23 |
|
Other funds holding IMGN
Fernwood Investment Management's IMGN Position: Q1 2024 in Review
Fernwood Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 83,780 shares — an estimated $2.48M sold.
Fernwood Investment Management first reported a position in IMGN in Q2 2017 and held it in 27 quarters. The position peaked at $2.48M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Fernwood Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Fernwood Investment Management sold 83,780 Immunogen Inc shares in Q1 2024, an estimated $2.48M.
- Fernwood Investment Management first reported a position in Immunogen Inc in Q2 2017 and held it in 27 quarters.
- Fernwood Investment Management's Immunogen Inc position peaked at $2.48M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Fernwood Investment Management's 13F filing for Q1 2024, filed 13 May 2024.